Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|17|27|3000-3016

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.17, Iss.27, 2017-11, pp. : 3000-3016

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-Target-Directed Ligands in Alzheimer's Disease Treatment

By  

Current Medicinal Chemistry, Vol. 18, Iss. 32, 2011-11 ,pp. : 4949-4975

Bentham Science Publishers

Access to resources Recommend Favorite

Multitarget-Directed Ligands: Innovative Chemical Probes and Therapeutic Tools Against Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 22, 2011-11 ,pp. : 2797-2806

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Agents for Alzheimer's Disease

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 4, 2005-01 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. : 3328-3335

Bentham Science Publishers

Access to resources Recommend Favorite

Hybrid-Based Multi-Target Ligands for the Treatment of Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 22, 2011-11 ,pp. : 2716-2730

Bentham Science Publishers

Access to resources Recommend Favorite